{"id":"https://openalex.org/W1999259477","doi":"https://doi.org/10.1021/jm970498o","title":"2-Substituted (2SR)-2-Amino-2-((1SR,2SR)-2-carboxycycloprop-1-yl)glycines as Potent and Selective Antagonists of Group II Metabotropic Glutamate Receptors. 2. Effects of Aromatic Substitution, Pharmacological Characterization, and Bioavailability","display_name":"2-Substituted (2SR)-2-Amino-2-((1SR,2SR)-2-carboxycycloprop-1-yl)glycines as Potent and Selective Antagonists of Group II Metabotropic Glutamate Receptors. 2. Effects of Aromatic Substitution, Pharmacological Characterization, and Bioavailability","publication_year":1998,"publication_date":"1998-01-01","ids":{"openalex":"https://openalex.org/W1999259477","doi":"https://doi.org/10.1021/jm970498o","mag":"1999259477","pmid":"https://pubmed.ncbi.nlm.nih.gov/9464367"},"language":"en","primary_location":{"id":"doi:10.1021/jm970498o","doi":"https://doi.org/10.1021/jm970498o","is_oa":false,"landing_page_url":"https://doi.org/10.1021/jm970498o","pdf_url":null,"source":{"id":"https://openalex.org/S162030435","display_name":"Journal of Medicinal Chemistry","issn_l":"0022-2623","issn":["0022-2623","1520-4804"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","jufo-3","ki-jl-2","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320006","host_organization_name":"American Chemical Society","host_organization_lineage":["https://openalex.org/P4310320006"],"host_organization_lineage_names":["American Chemical Society"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Medicinal Chemistry","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5036532125","display_name":"Paul L. Ornstein","orcid":"https://orcid.org/0000-0002-4335-1877","observed_orcids":["https://orcid.org/0000-0002-4335-1877"]},"institutions":[{"id":"https://openalex.org/I168537998","display_name":"Eli Lilly (United States)","ror":"https://ror.org/01qat3289","country_code":"US","type":"company","lineage":["https://openalex.org/I168537998"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Paul L. Ornstein","raw_affiliation_strings":["Lilly Research Laboratories, A Division of Eli Lilly and Company, Lilly Corporate Center, Indianapolis, Indiana 46285"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Lilly Research Laboratories, A Division of Eli Lilly and Company, Lilly Corporate Center, Indianapolis, Indiana 46285","institution_ids":["https://openalex.org/I168537998"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5032477659","display_name":"Thomas J. Bleisch","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I168537998","display_name":"Eli Lilly (United States)","ror":"https://ror.org/01qat3289","country_code":"US","type":"company","lineage":["https://openalex.org/I168537998"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Thomas J. Bleisch","raw_affiliation_strings":["Lilly Research Laboratories, A Division of Eli Lilly and Company, Lilly Corporate Center, Indianapolis, Indiana 46285"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Lilly Research Laboratories, A Division of Eli Lilly and Company, Lilly Corporate Center, Indianapolis, Indiana 46285","institution_ids":["https://openalex.org/I168537998"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110145956","display_name":"M. Brian Arnold","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I168537998","display_name":"Eli Lilly (United States)","ror":"https://ror.org/01qat3289","country_code":"US","type":"company","lineage":["https://openalex.org/I168537998"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"M. Brian Arnold","raw_affiliation_strings":["Lilly Research Laboratories, A Division of Eli Lilly and Company, Lilly Corporate Center, Indianapolis, Indiana 46285"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Lilly Research Laboratories, A Division of Eli Lilly and Company, Lilly Corporate Center, Indianapolis, Indiana 46285","institution_ids":["https://openalex.org/I168537998"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Joseph H. Kennedy","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I168537998","display_name":"Eli Lilly (United States)","ror":"https://ror.org/01qat3289","country_code":"US","type":"company","lineage":["https://openalex.org/I168537998"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Joseph H. Kennedy","raw_affiliation_strings":["Lilly Research Laboratories, A Division of Eli Lilly and Company, Lilly Corporate Center, Indianapolis, Indiana 46285"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Lilly Research Laboratories, A Division of Eli Lilly and Company, Lilly Corporate Center, Indianapolis, Indiana 46285","institution_ids":["https://openalex.org/I168537998"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111957779","display_name":"Rebecca A. Wright","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I168537998","display_name":"Eli Lilly (United States)","ror":"https://ror.org/01qat3289","country_code":"US","type":"company","lineage":["https://openalex.org/I168537998"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Rebecca A. Wright","raw_affiliation_strings":["Lilly Research Laboratories, A Division of Eli Lilly and Company, Lilly Corporate Center, Indianapolis, Indiana 46285"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Lilly Research Laboratories, A Division of Eli Lilly and Company, Lilly Corporate Center, Indianapolis, Indiana 46285","institution_ids":["https://openalex.org/I168537998"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113583844","display_name":"Bryan G. Johnson","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I168537998","display_name":"Eli Lilly (United States)","ror":"https://ror.org/01qat3289","country_code":"US","type":"company","lineage":["https://openalex.org/I168537998"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Bryan G. Johnson","raw_affiliation_strings":["Lilly Research Laboratories, A Division of Eli Lilly and Company, Lilly Corporate Center, Indianapolis, Indiana 46285"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Lilly Research Laboratories, A Division of Eli Lilly and Company, Lilly Corporate Center, Indianapolis, Indiana 46285","institution_ids":["https://openalex.org/I168537998"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109117254","display_name":"Joseph P. Tizzano","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I168537998","display_name":"Eli Lilly (United States)","ror":"https://ror.org/01qat3289","country_code":"US","type":"company","lineage":["https://openalex.org/I168537998"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Joseph P. Tizzano","raw_affiliation_strings":["Lilly Research Laboratories, A Division of Eli Lilly and Company, Lilly Corporate Center, Indianapolis, Indiana 46285"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Lilly Research Laboratories, A Division of Eli Lilly and Company, Lilly Corporate Center, Indianapolis, Indiana 46285","institution_ids":["https://openalex.org/I168537998"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5068627088","display_name":"David R. Helton","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I168537998","display_name":"Eli Lilly (United States)","ror":"https://ror.org/01qat3289","country_code":"US","type":"company","lineage":["https://openalex.org/I168537998"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"David R. Helton","raw_affiliation_strings":["Lilly Research Laboratories, A Division of Eli Lilly and Company, Lilly Corporate Center, Indianapolis, Indiana 46285"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Lilly Research Laboratories, A Division of Eli Lilly and Company, Lilly Corporate Center, Indianapolis, Indiana 46285","institution_ids":["https://openalex.org/I168537998"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110071815","display_name":"Mary Jeanne Kallman","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I168537998","display_name":"Eli Lilly (United States)","ror":"https://ror.org/01qat3289","country_code":"US","type":"company","lineage":["https://openalex.org/I168537998"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Mary Jeanne Kallman","raw_affiliation_strings":["Lilly Research Laboratories, A Division of Eli Lilly and Company, Lilly Corporate Center, Indianapolis, Indiana 46285"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Lilly Research Laboratories, A Division of Eli Lilly and Company, Lilly Corporate Center, Indianapolis, Indiana 46285","institution_ids":["https://openalex.org/I168537998"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5055799927","display_name":"Darryle D. Schoepp","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I168537998","display_name":"Eli Lilly (United States)","ror":"https://ror.org/01qat3289","country_code":"US","type":"company","lineage":["https://openalex.org/I168537998"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Darryle D. Schoepp","raw_affiliation_strings":["Lilly Research Laboratories, A Division of Eli Lilly and Company, Lilly Corporate Center, Indianapolis, Indiana 46285"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Lilly Research Laboratories, A Division of Eli Lilly and Company, Lilly Corporate Center, Indianapolis, Indiana 46285","institution_ids":["https://openalex.org/I168537998"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5111973790","display_name":"Marc F. Herin","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Marc H\u00e9rin","raw_affiliation_strings":["Lilly Development Centre S.A., Parc Scientifique de Louvain-la-Neuve, Rue Granbonpre, 11, 1348 Mont Saint-Guibert, Belgium"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Lilly Development Centre S.A., Parc Scientifique de Louvain-la-Neuve, Rue Granbonpre, 11, 1348 Mont Saint-Guibert, Belgium","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":4500,"currency":"USD","value_usd":4500},"apc_paid":null,"fwci":2.5919,"has_fulltext":false,"cited_by_count":99,"citation_normalized_percentile":{"value":0.90598654,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":93,"max":98},"biblio":{"volume":"41","issue":"3","first_page":"358","last_page":"378"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10077","display_name":"Neuroscience and Neuropharmacology Research","score":0.8579000234603882,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10077","display_name":"Neuroscience and Neuropharmacology Research","score":0.8579000234603882,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12770","display_name":"Amino Acid Enzymes and Metabolism","score":0.07479999959468842,"subfield":{"id":"https://openalex.org/subfields/1303","display_name":"Biochemistry"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11178","display_name":"Receptor Mechanisms and Signaling","score":0.02710000053048134,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/group-ii-metabotropic-glutamate-receptors","display_name":"group II metabotropic glutamate receptors","score":0.9559999704360962},{"id":"https://openalex.org/keywords/mglur2","display_name":"mGluR2","score":0.9150000214576721},{"id":"https://openalex.org/keywords/mglur3","display_name":"mGluR3","score":0.9959999918937683},{"id":"https://openalex.org/keywords/aromatic-substitution","display_name":"aromatic substitution","score":0.6129999756813049},{"id":"https://openalex.org/keywords/meta-substitution","display_name":"meta-substitution","score":0.6079999804496765},{"id":"https://openalex.org/keywords/receptor-antagonists","display_name":"receptor antagonists","score":0.7770000100135803},{"id":"https://openalex.org/keywords/receptor-binding-affinity","display_name":"receptor binding affinity","score":0.5770000219345093},{"id":"https://openalex.org/keywords/diastereomers","display_name":"diastereomers","score":0.7369999885559082},{"id":"https://openalex.org/keywords/bioavailability","display_name":"bioavailability","score":0.625},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.6150000095367432},{"id":"https://openalex.org/keywords/brain-distribution","display_name":"brain distribution","score":0.3009999990463257}],"concepts":[{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.9002461433410645},{"id":"https://openalex.org/C49051014","wikidata":"https://www.wikidata.org/wiki/Q2033959","display_name":"Metabotropic glutamate receptor","level":4,"score":0.7015619277954102},{"id":"https://openalex.org/C71240020","wikidata":"https://www.wikidata.org/wiki/Q186011","display_name":"Stereochemistry","level":1,"score":0.5889285802841187},{"id":"https://openalex.org/C2778938600","wikidata":"https://www.wikidata.org/wiki/Q389934","display_name":"Agonist","level":3,"score":0.5063103437423706},{"id":"https://openalex.org/C2776442012","wikidata":"https://www.wikidata.org/wiki/Q2302144","display_name":"Trifluoromethyl","level":3,"score":0.4658084511756897},{"id":"https://openalex.org/C2776885963","wikidata":"https://www.wikidata.org/wiki/Q245204","display_name":"Antagonist","level":3,"score":0.4552631676197052},{"id":"https://openalex.org/C138716334","wikidata":"https://www.wikidata.org/wiki/Q268477","display_name":"Diastereomer","level":2,"score":0.43296879529953003},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.21917766332626343},{"id":"https://openalex.org/C178790620","wikidata":"https://www.wikidata.org/wiki/Q11351","display_name":"Organic chemistry","level":1,"score":0.14285597205162048},{"id":"https://openalex.org/C2780263894","wikidata":"https://www.wikidata.org/wiki/Q335268","display_name":"Alkyl","level":2,"score":0.1173873245716095},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.09733390808105469}],"mesh":[{"descriptor_ui":"D000596","descriptor_name":"Amino Acids","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000927","descriptor_name":"Anticonvulsants","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D001682","descriptor_name":"Biological Availability","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004195","descriptor_name":"Disease Models, Animal","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005998","descriptor_name":"Glycine","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":true},{"descriptor_ui":"D005998","descriptor_name":"Glycine","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D005998","descriptor_name":"Glycine","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008032","descriptor_name":"Limbic System","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D008032","descriptor_name":"Limbic System","qualifier_ui":"Q000503","qualifier_name":"physiopathology","is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012640","descriptor_name":"Seizures","qualifier_ui":"Q000517","qualifier_name":"prevention & control","is_major_topic":false},{"descriptor_ui":"D013329","descriptor_name":"Structure-Activity Relationship","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018094","descriptor_name":"Receptors, Metabotropic Glutamate","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":true},{"descriptor_ui":"D018691","descriptor_name":"Excitatory Amino Acid Antagonists","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D018691","descriptor_name":"Excitatory Amino Acid Antagonists","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D051379","descriptor_name":"Mice","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D051381","descriptor_name":"Rats","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":3,"locations":[{"id":"doi:10.1021/jm970498o","doi":"https://doi.org/10.1021/jm970498o","is_oa":false,"landing_page_url":"https://doi.org/10.1021/jm970498o","pdf_url":null,"source":{"id":"https://openalex.org/S162030435","display_name":"Journal of Medicinal Chemistry","issn_l":"0022-2623","issn":["0022-2623","1520-4804"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","jufo-3","ki-jl-2","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320006","host_organization_name":"American Chemical Society","host_organization_lineage":["https://openalex.org/P4310320006"],"host_organization_lineage_names":["American Chemical Society"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Medicinal Chemistry","raw_type":"journal-article"},{"id":"pmid:9464367","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/9464367","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of medicinal chemistry","raw_type":"Journal Article"},{"id":"pmh:oai:dial.uclouvain.be:boreal:45512","doi":null,"is_oa":false,"landing_page_url":"http://hdl.handle.net/2078.1/45512","pdf_url":null,"source":{"id":"https://openalex.org/S4306401902","display_name":"Digital Access to Libraries (Universit\u00e9 catholique de Louvain (UCL), l'Universit\u00e9 de Namur (UNamur) and the Universit\u00e9 Saint-Louis (USL-B))","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I95674353","host_organization_name":"UCLouvain","host_organization_lineage":["https://openalex.org/I95674353"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Journal of Medicinal Chemistry, Vol. 41, no. 3, p. 358-378 (1998)","raw_type":"info:eu-repo/semantics/article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.4043000042438507}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":10,"referenced_works":["https://openalex.org/W1970596941","https://openalex.org/W1989452582","https://openalex.org/W2016375502","https://openalex.org/W2025396999","https://openalex.org/W2039248264","https://openalex.org/W2058591676","https://openalex.org/W2068761941","https://openalex.org/W2086166389","https://openalex.org/W2953310104","https://openalex.org/W4296367858"],"related_works":["https://openalex.org/W1980847901","https://openalex.org/W1985709851","https://openalex.org/W2110315049","https://openalex.org/W2025512517","https://openalex.org/W4390966290","https://openalex.org/W2129923095","https://openalex.org/W2055779394","https://openalex.org/W2058101809","https://openalex.org/W1995301403","https://openalex.org/W2950618851"],"abstract_inverted_index":{"In":[0],"this":[1,78,322],"paper":[2,79],"we":[3,80],"describe":[4],"the":[5,14,34,39,47,64,67,73,82,87,95,152,201,214,221,229,296,311,317,339,362,384],"synthesis":[6],"of":[7,10,13,30,46,56,66,84,136,155,160,228,264,298,353,386],"a":[8,31,54,91,158,204,262,379],"series":[9,55],"alpha-substituted":[11],"analogues":[12],"potent":[15,223,319],"and":[16,51,147,172,250,272,281,283,335],"selective":[17],"group":[18,101,106,287,387],"II":[19,102,107,288,388],"metabotropic":[20],"glutamate":[21],"receptor":[22],"(mGluR)":[23],"agonist":[24,40,364],"(1S,1'S,2'S)-carboxycyclopropylglycine":[25],"(2,":[26],"L-CCG":[27],"1).":[28],"Incorporation":[29],"substitutent":[32],"on":[33,86,151],"amino":[35,268],"acid":[36,113,325],"carbon":[37],"converted":[38],"2":[41],"into":[42,276,338],"an":[43,304,367],"antagonist.":[44],"All":[45],"compounds":[48,99,126,242],"were":[49,238,274],"prepared":[50],"tested":[52],"as":[53,90,192],"four":[57,278],"isomers,":[58,280],"i.e.,":[59],"two":[60,245,248,251],"racemic":[61],"diastereomers.":[62],"On":[63],"basis":[65],"improvement":[68,256],"in":[69,77,116,140,187,193,207,236,257,261,295,390],"affinity":[70,96,208,237,258,282],"realized":[71,210,239],"for":[72,100,105,124,212,240,286],"alpha-phenylethyl":[74],"analogue":[75],"3,":[76],"explored":[81],"effects":[83],"substitution":[85,150,265],"aromatic":[88,153],"ring":[89,154],"strategy":[92],"to":[93,97,131,184,292,382],"increase":[94,206],"these":[98,125],"mGluRs.":[103],"Affinity":[104],"mGluRs":[108,289,389],"was":[109,122,200,209,220,290,316],"measured":[110],"using":[111],"[3H]glutamic":[112],"(Glu)":[114],"binding":[115],"rat":[117],"forebrain":[118],"membranes.":[119],"Antagonist":[120],"activity":[121,285],"confirmed":[123],"by":[127,361],"measuring":[128],"their":[129,277],"ability":[130],"antagonize":[132],"(1S,3R)-1-aminocyclopentane-1,3-dicarboxylic":[133],"acid-induced":[134],"inhibition":[135],"forskolin":[137],"stimulated":[138],"cyclic-AMP":[139],"RGT":[141],"cells":[142],"transfected":[143],"with":[144,157,190,301,366],"human":[145],"mGluR2":[146],"mGluR3.":[148],"Meta":[149],"3":[156],"variety":[159,263],"substituents,":[161],"both":[162],"electron":[163,173],"donating":[164],"(e.g.,":[165,175],"methyl,":[166],"hydroxy,":[167],"amino,":[168],"methoxy,":[169],"phenyl,":[170],"phenoxy)":[171],"withdrawing":[174],"fluorine,":[176],"chlorine,":[177],"bromine,":[178],"carboxy,":[179],"trifluoromethyl)":[180],"gave":[181,254],"from":[182,226,321,357],"1.5-":[183],"4.5-fold":[185],"increases":[186,235],"affinity.":[188],"Substitution":[189],"p-fluorine,":[191],"97":[194,219],"(IC50":[195],"=":[196,306,369],"0.022":[197],"+/-":[198,308],"0.002),":[199],"exception.":[202],"Here,":[203],"greater":[205],"than":[211],"either":[213,244],"ortho-":[215],"or":[216,247],"meta-substituted":[217],"analogues;":[218],"most":[222,318],"compound":[224,314,320],"resulting":[225],"monosubstitution":[227],"aromatic.":[230],"At":[231],"best,":[232],"only":[233,345],"modest":[234],"certain":[241],"bearing":[243],"chlorines":[246],"fluorines,":[249],"methoxy":[252],"groups":[253],"no":[255],"(all":[259],"examined":[260],"patterns).":[266],"Three":[267],"acids,":[269],"4,":[270],"5,":[271],"104,":[273],"resolved":[275,312],"constituent":[279],"functional":[284],"found":[291],"reside":[293],"solely":[294],"S,S,S-isomers":[297],"each,":[299],"consistent":[300],"1.":[302],"With":[303],"IC50":[305],"2.9":[307],"0.6":[309],"nM,":[310],"xanthylmethyl":[313],"168":[315,326,354,377],"SAR.":[323],"Amino":[324],"demonstrated":[327],"high":[328],"plasma":[329],"levels":[330],"following":[331],"intraperitoneal":[332],"(i.p.)":[333],"administration":[334,352],"readily":[336],"penetrated":[337],"brain.":[340],"This":[341],"compound,":[342],"however,":[343],"had":[344],"limited":[346],"(approximately":[347],"5%)":[348],"oral":[349],"bioavailability.":[350],"Systemic":[351],"protected":[355],"mice":[356],"limbic":[358],"seizures":[359],"produced":[360],"mGluR":[363],"3,5-dihydroxyphenylglycine,":[365],"ED50":[368],"31":[370],"mg/kg":[371],"(i.p.,":[372],"60":[373],"min":[374],"preinjection).":[375],"Thus,":[376],"represents":[378],"valuable":[380],"tool":[381],"study":[383],"role":[385],"disease.":[391]},"counts_by_year":[{"year":2024,"cited_by_count":2},{"year":2022,"cited_by_count":2},{"year":2021,"cited_by_count":2},{"year":2020,"cited_by_count":3},{"year":2019,"cited_by_count":4},{"year":2018,"cited_by_count":5},{"year":2017,"cited_by_count":2},{"year":2016,"cited_by_count":3},{"year":2015,"cited_by_count":3},{"year":2014,"cited_by_count":5},{"year":2013,"cited_by_count":3},{"year":2012,"cited_by_count":4}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}